Showing results (241-250 of 293) with videos related to
Sort By:
Pageof 30
Bioorganic & Medicinal Chemistry|June 19, 2007
SAR study of bicyclo[4.1.0]heptanes as melanin-concentrating hormone receptor R1 antagonists: taming hERGJing Su, Brian A McKittrick, Haiqun Tang, et al.Bioorganic & Medicinal Chemistry Letters|January 24, 2007
Potent, selective, and orally active adenosine A2A receptor antagonists: arylpiperazine derivatives of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidinesBernard R Neustadt, Jinsong Hao, Neil Lindo, et al.Bioorganic & Medicinal Chemistry Letters|April 15, 2015
Discovery and hit-to-lead optimization of 2,6-diaminopyrimidine inhibitors of interleukin-1 receptor-associated kinase 4William T McElroy, W Michael Seganish, R Jason Herr, et al.Bioorganic & Medicinal Chemistry Letters|January 12, 2010
Discovery of new SCH 39166 analogs as potent and selective dopamine D1 receptor antagonistsLi Qiang, T K Sasikumar, Duane A Burnett, et al.Bioorganic & Medicinal Chemistry Letters|September 25, 2007
Discovery of 2,4,6-trisubstituted N-arylsulfonyl piperidines as gamma-secretase inhibitorsHongmei Li, Theodros Asberom, Thomas A Bara, et al.Nature Immunology|March 31, 2009
Divergent functions for airway epithelial matrix metalloproteinase 7 and retinoic acid in experimental asthmaSangeeta Goswami, Pornpimon Angkasekwinai, Ming Shan, et al.Bioorganic & Medicinal Chemistry Letters|November 9, 2007
Discovery of amide and heteroaryl isosteres as carbamate replacements in a series of orally active gamma-secretase inhibitorsMark D McBriar, John W Clader, Inhou Chu, et al.Bioorganic & Medicinal Chemistry Letters|July 3, 2007
Synthesis of novel bicyclo[4.1.0]heptane and bicyclo[3.1.0]hexane derivatives as melanin-concentrating hormone receptor R1 antagonistsJing Su, Haiqun Tang, Brian A McKittrick, et al.Nature Communications|May 5, 2025
Frontal polymerization of thermosets to enable vacuum-formed structural electronicsHayden E Fowler, Mychal S Taylor, Chi Phuong H Nguyen, et al.Bioorganic & Medicinal Chemistry Letters|December 7, 2011
Discovery of orally active pyrazoloquinolines as potent PDE10 inhibitors for the management of schizophreniaShu-Wei Yang, Jennifer Smotryski, William T McElroy, et al.Pageof 30